Biological agents in monotherapy for the treatment of rheumatoid arthritis by Cem Gabay, Paul Hasler, Diego Kyburz, Alexander So, Peter Villiger, Johannes von Kempis, Ulrich Walker

Get full text

Use of abatacept in rheumatoid arthritis by Johannes von Kempis, Jean Dudler, Paul Hasler, Diego Kyburz, Alan Tyndall, Pascal Zufferey, Peter M. Villiger

Get full text

Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in... by Johannes von Kempis, Sabine Duetsch, Nicola Reuschling, Rahel Villiger, Peter M Villiger, Florence Vallelian, Dominik J Schaer, Ruediger B Mueller

Get full text

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care by Myriam Riek, Almut Scherer, Burkhard Möller, Adrian Ciurea, Ines von Mühlenen, Cem Gabay, Diego Kyburz, Laure Brulhart, Johannes von Kempis, Ruediger B. Mueller, Paul Hasler, Tanja Strahm, Sabine von Känel, Pascal Zufferey, Jean Dudler, Axel Finckh

Get full text

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) – cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland... by Camillo Ribi, Marten Trendelenburg, Angèle Gayet-Ageron, Clemens Cohen, Eric Dayer, Ute Eisenberger, Thomas Hauser, Thomas Hunziker, Annette Leimgruber, Gregor Lindner, Katrin Koenig, Petra Otto, François Spertini, Thomas Stoll, Johannes Von Kempis, Carlo Chizzolini, Swiss Systemic Lupus Erythematosus Cohort Study Group

Get full text